Perinatal derivatives application: Identifying possibilities for clinical use.

Front Bioeng Biotechnol · 2022 · PMC9595339 · PMID 36304904

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a strong trendno p-value reported

There has been an increasing diversification of MSC products in the past decade, with preferential use of BM-MSCs until 2008, but increasing diversification since then with now equal use of BM, PT (perinatal tissues), and AT (adipose tissues)-derived cells, with a strong trend for PnD to become the most popular source in the past 2 years.

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.